| Responsible corporate citizenship |
- Safety record of SCENESSE® (afamelanotide 16mg) in over 16,000 administrations to EPP patients
- Regular pharmacovigilance reporting of patient experience to regulators
|
| Clinical testing involving humans, as required to obtain regulatory approval of pharmaceutical products |
- Adhere to OECD Testing Guidelines and principles of Good Laboratory Practices
- Privacy of study participants maintained
- Ethics committees approve studies
- PhotoCosmetic products tested on humans only
|
| Clinical testing involving non-humans |
- Adhere to OECD Replacement, Reduction and Refinement Principles
- Laboratories used meet international standards and certifications
|
| Facilitate a safe working environment |
- CLINUVEL's premsies are high quality and designed to enable active interation and collaboration
|
| Facilitate a positive working environment |
- Competitive performance-based remuneration and employment benefits
- HR policies support employee well-being, with leave for illness, including stress and post-menopausal care, maternity, paternity and family care
|
| Respect human rights |
- Support freedom of association and binary / non-binary designation
|
| Equal opportunity and people development |
- Policy of no tolerance in relation to discrimination
- Focus on career development through Individual Development Plans (all employees) and advanced development through the CLINUVEL Academy
|
| Leader in diversity – refer FY2024 metrics |
- Gender: Female / Male quotient (%): All employees (69/31%); Executives (Top seven excluding MD 57/43%); and Board (including MD 60/40%)
- Nationalities: 30
- Linguistics: 63% of employees speak more than one language
- Age: Generation Z (born 1997-2012) 19%; Generation Y, Millennials (1981-1996) 58%; Generation X (1965-1980) 19%; Baby Boomers (1946-1964) 4%
- Tenure: % of total employees; Up to 2 years 59%; +2 and up to 5 years 25%;+5 and up to 10 years 8%; Over 10 years 8%
|